12 reports of this reaction
1.1% of all POTASSIUM NITRATE, SODIUM FLUORIDE reports
#18 most reported adverse reaction
TOOTH DISCOLOURATION is the #18 most commonly reported adverse reaction for POTASSIUM NITRATE, SODIUM FLUORIDE, manufactured by Haleon US Holdings LLC. There are 12 FDA adverse event reports linking POTASSIUM NITRATE, SODIUM FLUORIDE to TOOTH DISCOLOURATION. This represents approximately 1.1% of all 1,087 adverse event reports for this drug.
Patients taking POTASSIUM NITRATE, SODIUM FLUORIDE who experience tooth discolouration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOOTH DISCOLOURATION is a less commonly reported adverse event for POTASSIUM NITRATE, SODIUM FLUORIDE, but still significant enough to appear in the safety profile.
In addition to tooth discolouration, the following adverse reactions have been reported for POTASSIUM NITRATE, SODIUM FLUORIDE:
The following drugs have also been linked to tooth discolouration in FDA adverse event reports:
TOOTH DISCOLOURATION has been reported as an adverse event in 12 FDA reports for POTASSIUM NITRATE, SODIUM FLUORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
TOOTH DISCOLOURATION accounts for approximately 1.1% of all adverse event reports for POTASSIUM NITRATE, SODIUM FLUORIDE, making it a notable side effect.
If you experience tooth discolouration while taking POTASSIUM NITRATE, SODIUM FLUORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.